From: Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours
 | Negative (P-Akt 0,1) | Positive (P-Akt 2,3) | Total |
---|---|---|---|
Negative (HER2 0,1; counted/expected) | 111/100.2 | 130/140.8 | 241 |
Positive (HER2 2,3; counted/expected) | 32/42.8 | 71/60.2 | 103 |
Total | 143 | 201 | 344 |